Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research

BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) act by increasing insulin secretion, decreasing glucagon secretion, slowing gastric emptying, and increasing satiety. OBJECTIVE: Published evidence directly comparing GLP-1RAs with other approved treatments for type 2 diabetes (T2D) wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Levin, Philip A, Nguyen, Hiep, Wittbrodt, Eric T, Kim, Seoyoung C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389657/
https://www.ncbi.nlm.nih.gov/pubmed/28435305
http://dx.doi.org/10.2147/DMSO.S130834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389657/
https://www.ncbi.nlm.nih.gov/pubmed/28435305
http://dx.doi.org/10.2147/DMSO.S130834

Ejemplares similares